Video

Educated Patient® Lung Cancer Summit Targeted Treatment Session: August 14, 2021

Author(s):

CURE Media Group

View the full CURE Educated Patient Lung Cancer Summit on demand.

Related Videos
Image of woman with black hair.
Image of a man wearing a black suit and tie.
Image of a man with white hair and a white goatee.
Image of Dr. Jorge Cortes; a man with short dark hair wearing a suit.
Image of a man with brown hair.
Image of a woman with short brown hair and glasses.
Image of a woman with short brown hair and glasses.
Image of a man with brown hair and a suit and tie.
Image of a woman with brown bobbed hair with glasses.
Image of Dr. Minesh Mehta at ASCO 2024.
Related Content
Illustration of lung.
October 8th 2024

Lazcluze Shows Central Nervous System Activity In EGFR-Variant NSCLC

Spencer Feldman
Lazcluze demonstrated significant CNS activity, regardless of T790M status, in treating intracranial and leptomeningeal metastases in patients with EGFR-variant NSCLC.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Cartoon image of a doctor on telehealth. Image generated by Adobe Firefly.
October 4th 2024

Telehealth Palliative Care Comparable to In-Person Visits

Alex Biese
Research has shown that among patients with advanced non-small cell lung cancer, early palliative care delivered by video is as effective as in-person care.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Illustration of lungs.
October 3rd 2024

Perioperative Opdivo Extends Event-Free Survival in Lung Cancer

Kyle Doherty
Receiving perioperative Opdivo for non-small cell lung cancer showed event-free survival benefits compared with placebo.
Picture of woman holding chest.
October 2nd 2024

Herceptin, Perjeta Regimen May Be Effective Without Chemo in Breast Cancer

Sabrina Serani
Among patients with HR+/HER2+ breast cancer, Herceptin and Perjeta plus endocrine therapy proved to be beneficial without chemotherapy.